KRISTINA BORDEAUX: Open Payments
NPI 1619695384 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,984 in 127 payments from 15 companies in 2025. Trend: 2023 $835 · 2024 $1,131 · 2025 $2,984
Food & beverage: $2,835Education: $149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $685 |
| Amgen Inc. | 38 | $642 |
| Janssen Biotech, Inc. | 8 | $366 |
| Novartis Pharmaceuticals Corporation | 19 | $332 |
| GlaxoSmithKline, LLC. | 4 | $209 |
| UCB, Inc. | 7 | $185 |
| GENZYME CORPORATION | 1 | $147 |
| AstraZeneca Pharmaceuticals LP | 2 | $108 |
| Lilly USA, LLC | 1 | $99 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
Products named: RINVOQ, TREMFYA, OTEZLA, COSENTYX, BENLYSTA, Bimzelx, KEVZARA, TAVNEOS.
Industry payments across LA — which companies pay providers there.
